Author(s): Nguyen PV; Dang-Vu T; Forest G; Saidi L; Desmarais P;
La présente étude de méthode mixte explore les perceptions et attentes relatives aux hypnotiques et produits de santé naturels (PSN) chez les personnes âgées. Vingt-quatre personnes d'en moyenne 76 ans dont 58 % étaient des femmes ont participé à des entrevues semi-structurées. La moitié était des utilisateurs d'hypnotiques. Selon leur score de l& ...
Article GUID: 40968485
Author(s): Nguyen PV; Dang-Vu TT; Forest G; Desjardins S; Forget MF; Vu TT; Nguyen QD; Kouassi E; Desmarais P;
Background: Mirtazapine promotes sleep by blocking serotonin and histaminergic receptors and is often used off-label to treat chronic insomnia. However, its efficacy remains to be demonstrated in a clinical trial. The MIRAGE study aims to determine the efficacy and safety of mirtazapine in older ...
Article GUID: 40135470
Author(s): Smith EE; Phillips NA; Feldman HH; Borrie M; Ganesh A; Henri-Bhargava A; Desmarais P; Frank A; Badhwar A; Barlow L; Bartha R; Best S; Bethell J; Bhangu J; Black SE; Bocti C; Bronskill SE; Burhan AM; Calon F; Camicioli R; Campbell B; Coll ...
Lecanemab and donanemab are monoclonal antibody therapies that remove amyloid-beta from the brain. They are the first therapies that alter a fundamental mechanism, amyloid-beta deposition, in Alzheimer disease (AD). To inform Canadian decisions on approval and use of these drugs, the Canadian Con ...
Article GUID: 39893139
- Page 1 / 1 -
